Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cristina Guarducci, Ph.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptors, Estrogen10202422100.910 Why?
Cyclin-Dependent Kinases120246560.720 Why?
Proto-Oncogene Proteins c-myc120249950.630 Why?
Cell Cycle1202429340.520 Why?
Cyclin-Dependent Kinase 4420245560.480 Why?
Breast Neoplasms132024210250.450 Why?
Protein Kinase Inhibitors3202456430.410 Why?
Drug Resistance, Neoplasm4202452530.410 Why?
Receptor, erbB-27202425540.380 Why?
Piperazines4202425250.350 Why?
Cyclin-Dependent Kinase 6320213460.330 Why?
Pyridines4202428790.320 Why?
Apoptosis2202495010.320 Why?
Antineoplastic Agents, Hormonal3201615290.210 Why?
Signal Transduction32024233760.200 Why?
Carcinoma, Lobular120224890.150 Why?
Genes, Retinoblastoma120181250.150 Why?
Xenograft Model Antitumor Assays1202435840.130 Why?
Carcinoma, Ductal, Breast1202210960.120 Why?
NF-kappa B1202324880.120 Why?
Neoplastic Cells, Circulating120219380.120 Why?
Retinoblastoma Protein120166700.110 Why?
Cell Line, Tumor32024169390.100 Why?
Estradiol2201619320.100 Why?
Cell Proliferation12024104460.080 Why?
Gene Expression Regulation, Neoplastic1202485150.080 Why?
Antineoplastic Agents22021136300.060 Why?
Tamoxifen220229630.060 Why?
Antineoplastic Combined Chemotherapy Protocols22020117120.050 Why?
Female1320243912700.050 Why?
Retinoblastoma Binding Proteins120211010.050 Why?
Apoptosis Regulatory Proteins1202311350.040 Why?
Antigen Presentation1202312540.040 Why?
Mitochondrial Proteins120239790.040 Why?
E2F2 Transcription Factor12016350.040 Why?
Mice12024812080.040 Why?
Cell Count1202118350.030 Why?
Humans1320247606210.030 Why?
Postmenopause2201625090.030 Why?
E2F1 Transcription Factor120161780.030 Why?
Receptors, Progesterone1202111300.030 Why?
Transcription Factor AP-212016790.030 Why?
Hepatocyte Nuclear Factor 3-alpha120161650.030 Why?
Biomarkers, Pharmacological120161620.030 Why?
Bayes Theorem1202323260.030 Why?
Animals220241679630.030 Why?
Phosphatidylinositol 3-Kinases1202428640.030 Why?
Epidermal Growth Factor120166950.030 Why?
Intracellular Signaling Peptides and Proteins1202328730.030 Why?
Tumor Cells, Cultured1202161310.030 Why?
Ubiquitin-Protein Ligases1202118890.020 Why?
Gene Expression Profiling2201894110.020 Why?
Aromatase Inhibitors120155110.020 Why?
Chromatin1202229380.020 Why?
Tumor Microenvironment1202338440.020 Why?
ROC Curve1201835680.020 Why?
Prognosis22022296580.020 Why?
Neoadjuvant Therapy1201828210.020 Why?
Disease-Free Survival1201668280.020 Why?
Neoplasm Metastasis1201549020.010 Why?
Disease Progression12021135020.010 Why?
Survival Analysis12016101820.010 Why?
Neoplasm Staging12018111520.010 Why?
Treatment Outcome22021650170.010 Why?
Double-Blind Method12016124270.010 Why?
Aged, 80 and over12018589950.010 Why?
Middle Aged220182203520.010 Why?
Mutation12016299320.010 Why?
Young Adult12018587410.010 Why?
Aged120181691520.000 Why?
Adult120182199940.000 Why?
Guarducci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.